|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 1998 |
FusionGeneSummary for ANXA5_USP48 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ANXA5_USP48 | Fusion gene ID: 1998 | Hgene | Tgene | Gene symbol | ANXA5 | USP48 | Gene ID | 308 | 84196 |
| Gene name | annexin A5 | ubiquitin specific peptidase 48 | |
| Synonyms | ANX5|ENX2|HEL-S-7|PP4|RPRGL3 | RAP1GA1|USP31 | |
| Cytomap | 4q27 | 1p36.12 | |
| Type of gene | protein-coding | protein-coding | |
| Description | annexin A5CBP-IPAP-IVAC-alphaanchorin CIIannexin Vannexin-5calphobindin Iendonexin IIepididymis secretory protein Li 7lipocortin Vplacental anticoagulant protein 4placental anticoagulant protein Ithromboplastin inhibitorvascular anticoagulan | ubiquitin carboxyl-terminal hydrolase 48deubiquitinating enzyme 48ubiquitin specific protease 31ubiquitin thioesterase 48ubiquitin thiolesterase 48ubiquitin-specific-processing protease 48 | |
| Modification date | 20180520 | 20180522 | |
| UniProtAcc | P08758 | Q86UV5 | |
| Ensembl transtripts involved in fusion gene | ENST00000296511, ENST00000501272, ENST00000515017, ENST00000509016, | ENST00000400301, ENST00000308271, ENST00000374732, ENST00000529637, ENST00000479177, ENST00000421625, | |
| Fusion gene scores | * DoF score | 4 X 5 X 2=40 | 7 X 8 X 6=336 |
| # samples | 5 | 8 | |
| ** MAII score | log2(5/40*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(8/336*10)=-2.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: ANXA5 [Title/Abstract] AND USP48 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BF381089 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000296511 | ENST00000400301 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-3CDS | ENST00000296511 | ENST00000308271 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-3CDS | ENST00000296511 | ENST00000374732 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-3CDS | ENST00000296511 | ENST00000529637 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-intron | ENST00000296511 | ENST00000479177 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-intron | ENST00000296511 | ENST00000421625 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-3CDS | ENST00000501272 | ENST00000400301 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-3CDS | ENST00000501272 | ENST00000308271 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-3CDS | ENST00000501272 | ENST00000374732 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-3CDS | ENST00000501272 | ENST00000529637 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-intron | ENST00000501272 | ENST00000479177 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-intron | ENST00000501272 | ENST00000421625 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-3CDS | ENST00000515017 | ENST00000400301 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-3CDS | ENST00000515017 | ENST00000308271 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-3CDS | ENST00000515017 | ENST00000374732 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-3CDS | ENST00000515017 | ENST00000529637 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-intron | ENST00000515017 | ENST00000479177 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-intron | ENST00000515017 | ENST00000421625 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-3CDS | ENST00000509016 | ENST00000400301 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-3CDS | ENST00000509016 | ENST00000308271 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-3CDS | ENST00000509016 | ENST00000374732 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-3CDS | ENST00000509016 | ENST00000529637 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-intron | ENST00000509016 | ENST00000479177 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
| intron-intron | ENST00000509016 | ENST00000421625 | ANXA5 | chr4 | 122593747 | + | USP48 | chr1 | 22028010 | + |
Top |
FusionProtFeatures for ANXA5_USP48 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ANXA5 | USP48 |
| This protein is an anticoagulant protein that acts as anindirect inhibitor of the thromboplastin-specific complex, whichis involved in the blood coagulation cascade. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ANXA5_USP48 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ANXA5_USP48 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ANXA5_USP48 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ANXA5_USP48 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | ANXA5 | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
| Hgene | ANXA5 | C0019202 | Hepatolenticular Degeneration | 1 | CTD_human |
| Hgene | ANXA5 | C0023467 | Leukemia, Myelocytic, Acute | 1 | CTD_human |
| Hgene | ANXA5 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Hgene | ANXA5 | C0026640 | Mouth Neoplasms | 1 | CTD_human |
| Hgene | ANXA5 | C0032914 | Pre-Eclampsia | 1 | CTD_human |
| Hgene | ANXA5 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
| Hgene | ANXA5 | C0043094 | Weight Gain | 1 | CTD_human |
| Hgene | ANXA5 | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
| Tgene | USP48 | C0236733 | Amphetamine-Related Disorders | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|